KRAS and colorectal carcinoma: Using [U-13C5]Gln as a tracer to monitor metabolic fluxes in KRAS-mutant CRC cells, we found that SLC25A21 depletion resulted in a significant increase in Gln-derived C4 metabolites, indicating that Gln metabolism is needed to fuel the TCA cycle.